Jeffrey B. Carroll
Affiliations: | 2004-2010 | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Google:
"Jeffrey Carroll"Mean distance: (not calculated yet)
Parents
Sign in to add mentorMichael R. Hayden | grad student | 2004-2010 | Western Washington University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Greco TM, Secker C, Ramos ES, et al. (2022) Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease. Cell Systems |
Malaiya S, Cortes-Gutierrez M, Herb BR, et al. (2021) Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
Minikel EV, Zhao HT, Le J, et al. (2020) Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Research |
Raymond GJ, Zhao HT, Race B, et al. (2019) Antisense oligonucleotides extend survival of prion-infected mice. Jci Insight. 5 |
Ament SA, Pearl JR, Cantle JP, et al. (2018) Transcriptional regulatory networks underlying gene expression changes in Huntington's disease. Molecular Systems Biology. 14: e7435 |
Kovalenko M, Milnerwood A, Giordano J, et al. (2018) HttQ111/+ Huntington's Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction. Journal of Huntington's Disease. 7: 17-33 |
Minnig S, Bragg RM, Tiwana HS, et al. (2018) Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools. Scientific Reports. 8: 2304 |
Coffey SR, Bragg RM, Minnig S, et al. (2017) Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease. Plos One. 12: e0175968 |
Ament SA, Pearl JR, Grindeland A, et al. (2017) High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds. Human Molecular Genetics |
Bragg RM, Coffey SR, Weston RM, et al. (2017) Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt(Q111/+) model of Huntington's disease. Scientific Reports. 7: 41570 |